AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents with atezolizumab (Atezo) for patients (pts) with recurrent or persistent endometrial cancer (EC).
- Citation:
- Internat J Gynecol Cancer vol 32 (3) TP010/#242
- Meeting Instance:
- IGCS 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- AFT
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None